Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tanya Partridge"'
Autor:
Ana Rosa Saez-Ibañez, Samik Upadhaya, Tanya Partridge, Monica Shah, Diego Correa, Jay Campbell
Publikováno v:
Nature reviews. Drug discovery. 21(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83f596c886418fb482579c402f7644f
https://pubmed.ncbi.nlm.nih.gov/35650421
https://pubmed.ncbi.nlm.nih.gov/35650421
Autor:
Bhavani Krishnan, Durga Vighnay, Michael Jeffrey Cho, Sari H. Enschede, Marie Given, Bernadette Collins, J. P. Hodge, Katarzyna Bochenska, Tanya Partridge
Publikováno v:
Journal of Clinical Oncology. 37:e19511-e19511
e19511 Background: The global burden of multiple myeloma (MM) has increased steadily in last 3 decades. The IARC reports there were ~160,000 new cases worldwide in 2018. There has been an increase in the development and approval of more effective tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e29fc1bf6bc74e6a6e192cadf1b7566
https://doi.org/10.1200/jco.2019.37.15_suppl.e19511
https://doi.org/10.1200/jco.2019.37.15_suppl.e19511
Autor:
Jeffrey Stewart, Natalia Balko Kotchie, Lisette Wagenaar, Nobumasa Kawasaki, Cyrille Leroy, Tanya Partridge, J. Ignacio Úbeda, Una Ria, Erika Rovati, Anirudh Singh Rathore, Charlotte Carey, Jeffrey Hodge
Publikováno v:
Journal of Clinical Oncology. 36:e16556-e16556
e16556Background: As of February 2018, there are 16 ongoing global Phase III clinical trials in mRCC (with 11 in the US) in the first-line setting involving 1300 sites and 9600 patients (pts). To i...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d93e7ecdc8bd32445f7cad59da11fdea
https://doi.org/10.1200/jco.2018.36.15_suppl.e16556
https://doi.org/10.1200/jco.2018.36.15_suppl.e16556